Drug Trial Radar · NCT07891910
Iopidine to Decrease Intraocular Pressure Rise After Injections
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Oct 1, 2026
Primary completion
Dec 1, 2026
Study completion Jan 1, 2027
Sponsor
- Lead sponsor
- Retina Consultants of DelmarvaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, randomized, controlled, open-label, single-site investigator-initiated clinical trial. A total of 120 participants will be randomized in a 1:1 ratio either to receive one drop of apraclonidine 1% ophthalmic solution (Iopidine) approximately 20-30 minutes before a clinically indicated intravitreal injection of Eylea HD or Syfovre, or to a control group that will receive no pre-injection study medication. The intravitreal injection is part of the participant's routine clinical care. The research-specific intervention for participants assigned to the Iopidine group is administration of Iopidine. Participants assigned to the control group will receive no pre-injection study medication. Both groups will undergo post-injection IOP assessments at 5, 15, and 30 minutes post-injection and transient-vision-loss assessments.
Conditions
- Macular Degeneration
- Diabetic Retinopathy
- Retinal Vein Occlusion
- Glaucoma
Interventions
Apraclonidine 1.0% ophthalmic solutionDrug
One drop prior to intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Intraocular pressure one minute after injectionTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Retina Consultants of Delmarva
Easton, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.